Ever since JUSTE introduced in 1989 the first antidepressant of the serotonin recapture inhibitor family in Spain, we have added important products in psychiatry and neurology, making the Central Nervous System (CNS) area a strategic element within our company.
Juste’s CNS line is supported by a specific network of 25 specialised individuals who bring to medical specialists within this therapeutic area our products for treating depression, epilepsy and ADHD in adults, adolescents and children.
Our brands are firmly established in these markets, a position that we strive to maintain by working on important innovations within these sectors, which will see the light in the near future.